TECH · NASDAQ · Biotechnology

Bio-Techne (TECH)

Supplies protein reagents, analysis instruments, spatial assays, and diagnostic controls.

$72.50
After hours−0.05 (−0.07%)
At close$72.55(+0.11%)

In millions of USD, except per-share figures

In millionsQ1 FY24Sep 2023Q2 FY24Dec 2023Q3 FY24Mar 2024Q4 FY24Jun 2024Q1 FY25Sep 2024Q2 FY25Dec 2024Q3 FY25Mar 2025Q4 FY25Jun 2025Q1 FY26Sep 2025Q2 FY26Dec 2025Q3 FY26Mar 2026Q4 FY26Jun 2026
Revenue277273303306289297316317287296311321
Cost of revenue92969910310610310211898105103110
Gross profit185177205203183194215199188191208211
129139138158143146176223140137133137
Research & development242326242425252624232324
1051161126011912115123116114109113
General & administrative00000000000113
Other expenses000730001730000
Operating income56386746404739−2448547574
−6−5−6−40−5010−4−4−4
Interest income11111111111−3
Interest expense54432222323−3
Other non-operating income1022−22−2−3−3217
Income before tax50336142404338−2348517171
Income tax expense−161217816−510132016
Net income from continuing operations51274941343523−1838385155
Other adjustments000000000000
Net income51274941343523−1838385155
EPS, basic$0.32$0.17$0.31$0.26$0.21$0.22$0.14−$0.11$0.25$0.24$0.33$0.35
EPS, diluted$0.31$0.17$0.31$0.25$0.21$0.22$0.14−$0.11$0.24$0.24$0.32$0.36
Weighted average shares, basic158158157158159158157155155156156156
Weighted average shares, diluted162160160161161161159156156157157157
EBITDA83669272707268675789992
Depreciation & amortization292827282827282724252424
EBIT54386544424540−2151537468